Fast set-up. Confident results. From discovery to manufacturing.

Gyros Protein Technologies provides a comprehensive menu of qualified consumables for Gyrolab assays designed to speed up development and validation of biopharmaceuticals, vaccines, and cell and gene therapies.

Our wide range of Gyrolab CDs, ready-to-use assay kits and solutions help biopharmaceutical companies reduce time-to-market by accelerating assay development in pre-clinical and clinical phases and facilitate upstream and downstream bioprocessing and streamline quality control in manufacturing.

Gyrolab assays provides the following features and benefits:

  • Ready-to-use assay kits and protocols save assay development time. Up to 112 data points per CD run in one hour maximizes productivity.
  • Analysis in nanoliter scale saves precious samples and reagents.
  • Wide dynamic range and extended sensitivity support a wide range of applications and reduce dilution requirements.
  • Minimal matrix interference and exceptional reproducibility minimize need for replicates and re-runs.

Gyrolab assays are used in virtually all major biopharmaceutical companies and CROs for a wide range of analyses including pharmacokinetics (PK)/toxicokinetics (TK), pharmacodynamics (PD) and biomarker monitoring, immunogenicity, affinity, product titer quantification and impurity testing.